Radiotherapy Market Size & Growth Forecast 2027–2036, By Segments (Type, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Radiotherapy Market size stood at USD 8.09 Billion in 2026 and is predicted to grow at 6.36% CAGR from 2027 to 2036, surpassing USD 14.99 Billion by 2036. The industry revenue for 2027 is estimated at USD 8.53 Billion.
Get more details on this report
Request Free Sample ReportRadiotherapy Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to advanced oncology infrastructure, broad access to sophisticated radiation technologies, and substantial healthcare investment supporting precision-based cancer care.
- Asia Pacific is the fastest-growing region, supported by rising cancer burden, improving healthcare infrastructure, expanding treatment facilities, and greater investment in advanced oncology services.
Segment Momentum
- External Beam Radiation Therapy accounted for 62.3% of the market in 2026 due to broad clinical use, advanced treatment planning, and its ability to deliver precise radiation while minimizing damage to healthy tissues.
- Prostate cancer is projected to be the fastest-growing application as advanced radiation techniques enable more precise treatment, fewer side effects, and greater adoption of non-invasive cancer therapies.
Market Expansion Drivers
- Rising global cancer incidence driving sustained demand for advanced radiotherapy treatments
- Technological advancements in precision radiotherapy improving treatment accuracy and outcomes
- Expanding oncology infrastructure and healthcare investments enabling wider radiotherapy access in emerging markets
Leading Market Participants
- Leading companies in the radiotherapy market include Elekta AB (Sweden), Accuray Incorporated (United States), Brainlab AG (Germany), Canon Medical Systems Corporation (Japan), Mitsubishi Electric Corporation (Japan), Toshiba Energy Systems & Solutions Corporation (Japan), Mevion Medical Systems, Inc. (United States), RefleXion Medical, Inc. (United States), Ion Beam Applications S.A. (Belgium)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.09 Billion
- 2027 Estimated Market Size: USD 8.53 Billion
- Projected Market Size: USD 14.99 Billion by 2036
- Growth Forecast: 6.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: External Beam Radiation Therapy (Type) | Hospitals (End Use) | Breast Cancer (Application)
- Emerging Opportunity Segment: Systemic Radiation Therapy (Type) | Radiotherapy Centers and Ambulatory Surgery Centers (End Use) | Prostate Cancer (Application)
Market Growth Drivers and Industry Trends
Rising global cancer incidence driving sustained demand for advanced radiotherapy treatments
The increasing prevalence of cancer worldwide is creating sustained demand for effective treatment options, making the radiotherapy market an essential component of modern oncology care. Radiotherapy remains a widely utilized treatment approach for multiple cancer types, either as a standalone therapy or in combination with surgery, chemotherapy, and immunotherapy. As healthcare providers manage growing patient volumes, the need for advanced radiation treatment systems capable of delivering effective and individualized therapies continues to expand across healthcare settings.
Technological advancements in precision radiotherapy improving treatment accuracy and outcomes
Continuous innovation in radiation delivery technologies is improving clinical precision and treatment effectiveness, which will propel the radiotherapy market growth. Advanced imaging integration, treatment planning software, adaptive therapy techniques, and highly targeted radiation delivery enable clinicians to focus therapeutic doses more accurately while minimizing exposure to surrounding healthy tissues. These technological improvements support personalized treatment strategies and enhance the ability of healthcare providers to manage complex oncology cases with greater confidence.
Expanding oncology infrastructure and healthcare investments enabling wider radiotherapy access in emerging markets
Growing investments in healthcare infrastructure and specialized oncology services are strengthening access to cancer treatment, and the radiotherapy market is benefiting from broader availability of advanced therapeutic capabilities in emerging economies. The establishment of dedicated cancer centers, modernization of hospital facilities, and expansion of radiation treatment capacity are improving access for larger patient populations. These developments are also encouraging the adoption of modern radiotherapy systems supported by trained clinical professionals and integrated cancer care services.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cancer incidence driving sustained demand for advanced radiotherapy treatments | 2% | High | North America, Europe | High | Near Term |
| Technological advancements in precision radiotherapy improving treatment accuracy and outcomes | 1.8% | High | Europe, Asia Pacific | High | Mid Term |
| Expanding oncology infrastructure and healthcare investments enabling wider radiotherapy access in emerging markets | 1.6% | High | Asia Pacific, Latin America | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest position in the radiotherapy market in 2026, supported by advanced oncology infrastructure, broad access to sophisticated radiation treatment technologies, and substantial healthcare investment. The region's established network of cancer treatment centers and increasing emphasis on precision-based cancer care are strengthening the adoption of advanced radiotherapy approaches. Growing demand for minimally invasive and targeted treatment options, combined with improvements in treatment planning and radiation delivery, is also supporting regional market development. Continued investment in healthcare technology and the expansion of specialized cancer care capabilities are expected to reinforce North America's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to register the fastest growth, driven by the rising cancer burden, improving healthcare infrastructure, and increasing investment in advanced oncology services. Growing healthcare expenditure and the expansion of specialized treatment facilities are improving access to radiotherapy across emerging healthcare markets. In addition, greater awareness of cancer screening and treatment, government efforts to strengthen cancer care capacity, and the gradual adoption of technologically advanced radiation treatment systems are creating favorable conditions for regional expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Precision Oncology AdoptionThe U.S. radiotherapy market emphasizes advanced treatment technologies that improve targeting accuracy and clinical workflow efficiency. Healthcare providers continue expanding access to image-guided systems and integrated cancer care solutions that support personalized treatment planning.
Germany 🇩🇪
Advanced Treatment IntegrationGermany prioritizes radiotherapy technologies that combine precision treatment with standardized clinical protocols. Hospitals and cancer centers invest in equipment upgrades, workflow optimization, and multidisciplinary care models to improve treatment consistency and patient outcomes.
Japan 🇯🇵
High-Accuracy Cancer CareJapan strengthens its radiotherapy market through adoption of highly precise treatment systems designed for complex oncology cases. Medical institutions emphasize reliable treatment delivery, efficient resource utilization, and integration with comprehensive cancer management programs.
South Korea 🇰🇷
Digital Oncology InfrastructureSouth Korea integrates radiotherapy equipment with advanced imaging and digital healthcare systems to enhance treatment planning. Cancer centers focus on improving workflow efficiency, clinical precision, and coordinated oncology services across specialized healthcare facilities.
France 🇫🇷
Comprehensive Cancer ServicesFrance supports radiotherapy adoption through coordinated cancer treatment networks and continued modernization of clinical infrastructure. Healthcare providers prioritize technologies that improve treatment accuracy, patient throughput, and multidisciplinary oncology collaboration.
Italy 🇮🇹
Hospital Modernization FocusItaly expands radiotherapy capabilities by upgrading hospital oncology departments with advanced treatment technologies. The market emphasizes reliable equipment, efficient treatment scheduling, and integrated care pathways that improve the overall delivery of radiation therapy services.
Segment Leadership and Growth Trends
Radiotherapy Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: External Beam Radiation Therapy (Largest Segment) vs Systemic Radiation Therapy (Fastest-Growing Segment)
External beam radiation therapy dominated the radiotherapy market and accounted for 62.3% of the market share in 2026. Its leading position is supported by widespread clinical adoption across multiple cancer indications, the availability of advanced treatment planning technologies, and its ability to deliver highly targeted radiation while minimizing damage to surrounding healthy tissues. Continuous improvements in imaging guidance, treatment precision, and workflow efficiency have further strengthened its role as the standard approach in modern radiation oncology.
The systemic radiation therapy segment is expected to witness the fastest growth as targeted radiopharmaceutical therapies gain wider acceptance for treating specific cancers. Ongoing advancements in precision medicine, increasing emphasis on personalized treatment strategies, and the growing availability of targeted radioactive agents are expanding the clinical application of systemic therapies. Their ability to selectively target cancer cells while complementing other treatment modalities is expected to support continued adoption.
End Use Segment Analysis: Hospitals (Largest Segment) vs Radiotherapy Centers and Ambulatory Surgery Centers (Fastest-Growing Segment)
The hospitals segment held the largest share of 44.41% in 2026. Hospitals remain the primary providers of radiotherapy services because they offer comprehensive oncology care supported by multidisciplinary medical teams, advanced imaging capabilities, and access to sophisticated radiation treatment systems. Their ability to manage complex cancer cases while integrating surgery, chemotherapy, and radiation therapy within a single healthcare setting continues to reinforce their market leadership.
In the radiotherapy market, radiotherapy centers and ambulatory surgery centers are anticipated to register the fastest growth. Rising demand for specialized cancer treatment facilities, shorter patient waiting times, and greater accessibility to outpatient oncology services are encouraging patients and healthcare providers to utilize dedicated treatment centers. Continued investments in advanced radiotherapy equipment and the expansion of specialized oncology networks are expected to accelerate growth within this segment.
Application Segment Analysis: Breast Cancer (Largest Segment) vs Prostate Cancer (Fastest-Growing Segment)
The breast cancer segment led the radiotherapy market and captured 31.1% of the market share in 2026. Radiotherapy remains an essential component of breast cancer treatment following breast-conserving surgery and in selected post-mastectomy cases, helping reduce recurrence while improving long-term treatment outcomes. Greater awareness, widespread screening initiatives, and established clinical treatment protocols continue to sustain strong demand for radiotherapy in breast cancer management.
The prostate cancer segment is projected to experience the fastest growth due to increasing adoption of advanced radiation techniques that enable precise dose delivery while minimizing side effects. Growing preference for non-invasive treatment options, expanding availability of image-guided and intensity-modulated radiotherapy, and increasing diagnosis among aging populations are contributing to stronger utilization of radiotherapy for prostate cancer care.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy | External Beam Radiation Therapy | Systemic Radiation Therapy |
| End Use | Hospitals, Radiotherapy Centers and Ambulatory Surgery Centers, Cancer Research Institutes | Hospitals | Radiotherapy Centers and Ambulatory Surgery Centers |
| Application | Lung Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Others | Breast Cancer | Prostate Cancer |
Competitive Landscape and Market Positioning
Major players in the radiotherapy market:
- Elekta AB (Sweden)
- Accuray Incorporated (United States)
- Brainlab AG (Germany)
- Canon Medical Systems Corporation (Japan)
- Mitsubishi Electric Corporation (Japan)
- Toshiba Energy Systems & Solutions Corporation (Japan)
- Mevion Medical Systems, Inc. (United States)
- RefleXion Medical, Inc. (United States)
- Ion Beam Applications S.A. (Belgium)
The radiotherapy market is experiencing a competitive transition as providers focus on advancing treatment precision, workflow efficiency, and patient-specific care capabilities. Differentiation is increasingly driven by the ability to integrate sophisticated imaging, treatment planning, and delivery technologies that improve clinical outcomes while addressing the operational demands of modern oncology centers. Market participants with strong expertise in developing comprehensive radiation therapy ecosystems are strengthening their positions, while specialized innovators are targeting opportunities through focused solutions for complex treatment applications. The competitive environment is also being influenced by the growing need for systems that support automation, reduce treatment complexity, and enable broader access to advanced cancer care.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Elekta AB (Sweden) | |||||||
| Accuray Incorporated (United States) | |||||||
| Brainlab AG (Germany) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Mitsubishi Electric Corporation (Japan) | |||||||
| Toshiba Energy Systems & Solutions Corporation (Japan) | |||||||
| Mevion Medical Systems Inc. (United States) | |||||||
| RefleXion Medical Inc. (United States) | |||||||
| Ion Beam Applications S.A. (Belgium) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Leo Cancer Care | Jul-26 | Leo Cancer Care secured $65 million in financing to accelerate the commercialization of its upright radiotherapy system. The company also entered a strategic partnership with an international healthcare company ahead of a planned public listing. |
| United Imaging | May-26 | United Imaging received CE Mark approval for its CT-linac system. The regulatory milestone and presentation of its full portfolio at ESTRO 2026 support the company's geographic and commercial expansion into the European radiotherapy market. |
| Institut Curie | Mar-25 | Institut Curie initiated patient treatments utilizing a new MRI-Linac adaptive radiotherapy system. The deployment is part of a €56 million capital investment program designed to scale the institution's advanced radiation therapy infrastructure. |
| Novartis | Sep-24 | Novartis expanded its production infrastructure by establishing in-house isotope manufacturing and constructing a new West Coast facility. The expansion secures the supply chain and delivery capacity for its targeted radiopharmaceutical portfolio. |
| Elekta | May-24 | Elekta expanded its software intellectual property through the acquisition of Philips Healthcare's Pinnacle Treatment Planning System patent portfolio. The transaction enhances Elekta's capabilities in radiation therapy treatment planning software. |
| Nucleus RadioPharma | May-24 | Nucleus RadioPharma entered a manufacturing partnership with ARTBIO to produce a clinical-stage prostate cancer radiopharmaceutical candidate. The agreement expands specialized contract manufacturing footprint within the targeted radiotherapy segment. |
| MIM Software | Apr-24 | GE Healthcare's subsidiary, MIM Software, expanded its collaboration with Elekta AB to co-develop advanced radiation therapy software. This initiative deepens their previous hardware-focused hospital supply agreement into digital oncology workflows. |
| Affidea | Mar-24 | Affidea acquired a Romanian radiotherapy provider operating four regional cancer care locations. The acquisition expands Affidea's healthcare service network and solidifies its clinical oncology market share in Eastern Europe. |
| Novartis | Jan-24 | Novartis secured U.S. FDA approval for its Indianapolis production facility. The regulatory clearance permits commercial manufacturing of Pluvicto, significantly expanding the company's radiopharmaceutical production capacity. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Radiotherapy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Intent | Curative Treatment, Adjuvant Treatment, Neoadjuvant Treatment, Palliative Treatment |
| Treatment Delivery Technique | Conventional Radiotherapy, 3D Conformal Radiotherapy, Intensity-Modulated Radiotherapy, Image-Guided Radiotherapy, Stereotactic Radiotherapy |
| Reimbursement Type | Publicly Reimbursed, Privately Reimbursed, Self-pay |
Radiotherapy Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Radiotherapy Access and Capacity Expansion |
|
| Oncology Care Pathway Integration |
|
| Emerging Therapy Adoption Pathways |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of radiotherapy?
How much is the radiotherapy industry expected to grow by 2036?
How are precision radiotherapy technologies influencing treatment adoption?
Why are healthcare infrastructure investments important for radiotherapy market expansion?
Why is External Beam Radiation Therapy the leading type in the radiotherapy market?
Which application segment is expected to grow the fastest in the radiotherapy market?
Why does North America lead the radiotherapy market?
What is driving radiotherapy market growth in Asia Pacific?
Which companies dominate the radiotherapy landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization